Citation Tools
PDFPlenary sessions
Plenary 6
IGCS19-0174
38 Phase II study of enzalutamide in androgen receptor positive (AR+) recurrent ovarian cancer: final results
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 38 Phase II study of enzalutamide in androgen receptor positive (AR+) recurrent ovarian cancer: final results